-
Electronic (PDF)
-
Hard Copy
-
CD ROM
-
Site License
-
Enterprisewide
Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2012
Fore Pharma, October 2012, Pages: 24
Fore Pharma announced the results of its Type 1 Diabetes patient population study in a new report ‘Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2012’. The report provides insights into Type 1 Diabetes epidemiology, Type 1 Diabetes diagnosed patients, and Type 1 Diabetes treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Type 1 Diabetes derived from epidemiological analysis, percentage of patients diagnosed with Type 1 Diabetes, and percentage of patients treated with Type 1 Diabetes therapy.
The study helps executives estimate Type 1 Diabetes market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Type 1 Diabetes prevalence, Type 1 Diabetes diagnosis rate, and Type 1 Diabetes treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Type 1 Diabetes: Disease Definition
- Type 1 Diabetes Patient Flow
- Type 1 Diabetes Prevalence
- Type 1 Diabetes Diagnosed Patients
- Type 1 Diabetes Treated Patients
1. Type 1 Diabetes: Disease Definition
2. Global Type 1 Diabetes Patient Flow
2A. Global Type 1 Diabetes Prevalence
2B. Global Type 1 Diabetes Diagnosed Patients
2C. Global Type 1 Diabetes Treated Patients
3. Type 1 Diabetes Patient Flow in the US
3A. Type 1 Diabetes Prevalence in the US
3B. Type 1 Diabetes Diagnosed Patients in the US
3C. Type 1 Diabetes Treated Patients in the US
4. Type 1 Diabetes Patient Flow in Europe
4A. Type 1 Diabetes Prevalence in Europe
4B. Type 1 Diabetes Diagnosed Patients in Europe
4C. Type 1 Diabetes Treated Patients in Europe
5. Type 1 Diabetes Patient Flow in Germany
5A. Type 1 Diabetes Prevalence in Germany
5B. Type 1 Diabetes Diagnosed Patients in Germany
5C. Type 1 Diabetes Treated Patients in Germany
6. Type 1 Diabetes Patient Flow in France
6A. Type 1 Diabetes Prevalence in France
6B. Type 1 Diabetes Diagnosed Patients in France
6C. Type 1 Diabetes Treated Patients in France
7. Type 1 Diabetes Patient Flow in Spain
7A. Type 1 Diabetes Prevalence in Spain
7B. Type 1 Diabetes Diagnosed Patients in Spain
7C. Type 1 Diabetes Treated Patients in Spain
8. Type 1 Diabetes Patient Flow in Italy
8A. Type 1 Diabetes Prevalence in Italy
8B. Type 1 Diabetes Diagnosed Patients in Italy
8C. Type 1 Diabetes Treated Patients in Italy
9. Type 1 Diabetes Patient Flow in UK
9A. Type 1 Diabetes Prevalence in UK
9B. Type 1 Diabetes Diagnosed Patients in UK
9C. Type 1 Diabetes Treated Patients in UK
10. Type 1 Diabetes Patient Flow in Japan
10A. Type 1 Diabetes Prevalence in Japan
10B. Type 1 Diabetes Diagnosed Patients in Japan
10C. Type 1 Diabetes Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources
Table 1: Global Type 1 Diabetes Patient Flow (2012)
Table 2: Global Type 1 Diabetes Patient Flow Forecast (2012-2019)
Table 3: Type 1 Diabetes Patient Flow in the US (2012)
Table 4: Type 1 Diabetes Patient Flow Forecast in the US (2012-2019)
Table 5: Type 1 Diabetes Patient Flow in Europe (2012)
Table 6: Type 1 Diabetes Patient Flow Forecast in Europe (2012-2019)
Table 7: Type 1 Diabetes Patient Flow in Germany (2012)
Table 8: Type 1 Diabetes Patient Flow Forecast in Germany (2012-2019)
Table 9: Type 1 Diabetes Patient Flow in France (2012)
Table 10: Type 1 Diabetes Patient Flow Forecast in France (2012-2019)
Table 11: Type 1 Diabetes Patient Flow in Spain (2012)
Table 12: Type 1 Diabetes Patient Flow Forecast in Spain (2012-2019)
Table 13: Type 1 Diabetes Patient Flow in Italy (2012)
Table 14: Type 1 Diabetes Patient Flow Forecast in Italy (2012-2019)
Table 15: Type 1 Diabetes Patient Flow in UK (2012)
Table 16: Type 1 Diabetes Patient Flow Forecast in UK (2012-2019)
Table 17: Type 1 Diabetes Patient Flow in Japan (2012)
Table 18: Type 1 Diabetes Patient Flow Forecast in Japan (2012-2019)
Figure 1: Global Type 1 Diabetes Patient Flow (2012)
Figure 2: Global Type 1 Diabetes Patient Flow Forecast (2012-2019)
Figure 3: Type 1 Diabetes Patient Flow in the US (2012)
Figure 4: Type 1 Diabetes Patient Flow Forecast in the US (2012-2019)
Figure 5: Type 1 Diabetes Patient Flow in Europe (2012)
Figure 6: Type 1 Diabetes Patient Flow Forecast in Europe (2012-2019)
Figure 7: Type 1 Diabetes Patient Flow in Germany (2012)
Figure 8: Type 1 Diabetes Patient Flow Forecast in Germany (2012-2019)
Figure 9: Type 1 Diabetes Patient Flow in France (2012)
Figure 10: Type 1 Diabetes Patient Flow Forecast in France (2012-2019)
Figure 11: Type 1 Diabetes Patient Flow in Spain (2012)
Figure 12: Type 1 Diabetes Patient Flow Forecast in Spain (2012-2019)
Figure 13: Type 1 Diabetes Patient Flow in Italy (2012)
Figure 14: Type 1 Diabetes Patient Flow Forecast in Italy (2012-2019)
Figure 15: Type 1 Diabetes Patient Flow in UK (2012)
Figure 16: Type 1 Diabetes Patient Flow Forecast in UK (2012-2019)
Figure 17: Type 1 Diabetes Patient Flow in Japan (2012)
Figure 18: Type 1 Diabetes Patient Flow Forecast in Japan (2012-2019)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
